Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Minimally Invasive Procedures
4.2.2 Emergence of Novel Products
4.2.3 Increasing Prevalence of Chronic Diseases
4.3 Market Restraints
4.3.1 High Cost of Devices
4.3.2 Stringent Regulatory Requirements
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Drug Infusion Pumps
5.1.2 Intraocular Drug Delivery Devices
5.1.3 Contraceptive Drug Delivery Devices
5.1.4 Stents
5.1.5 Others
5.2 By Technology
5.2.1 Biodegradable Implants
5.2.2 Non-biodegradable Implants
5.3 By Application
5.3.1 Oncology
5.3.2 Cardiovascular
5.3.3 Autoimmune Diseases
5.3.4 Obstetrics and Gynecology
5.3.5 Other Applications
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan
6.1.2 Boston Scientific Corporation
6.1.3 Bausch and Lomb Inc.
6.1.4 Delpor Inc.
6.1.5 Medtronic
6.1.6 Novartis (Alcon)
6.1.7 pSivida Corp.
6.1.8 Teleflex Incorporated
6.1.9 DSM Biomedical
6.1.10 TissueGen, Inc.
6.1.11 3M


7 MARKET OPPORTUNITIES AND FUTURE TRENDS